Search Results

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly

Authors: Vieweg, W. Victor R.; Wood, Mark A.; Fernandez, Antony; Beatty-Brooks, Mary; Hasnain, Mehrul; Pandurangi, Anand K.

Source: Drugs & Aging, Volume 26, Number 12, 1 December 2009 , pp. 997-1012(16)

Publisher: Adis International

Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications

Authors: Marano, Giuseppe; Harnic, Desiree; Lotrionte, Marzia; Biondi-Zoccai, Giuseppe; Abbate, Antonio; Romagnoli, Enrico; Mazza, Marianna

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 9, September 2009 , pp. 1123-1147(25)

Publisher: Expert Reviews

Adverse effects of medications commonly used in the treatment of migraine

Authors: Whyte, Chad A; Tepper, Stewart J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 9, September 2009 , pp. 1379-1391(13)

Publisher: Expert Reviews

Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials: A Systematic Review and Meta-Analysis

Authors: Rief, Winfried; Nestoriuc, Yvonne; >Anna von Lilienfeld-Toal,; Dogan, Imis; Schreiber, Franziska; Hofmann, Stefan G.; Barsky, Arthur J.; Avorn, Jerry

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1041-1056(16)

Publisher: Adis International

Is elevated noradrenaline an aetiological factor in a number of diseases?

Author: Fitzgerald, P. J.

Source: Autonomic & Autacoid Pharmacology, Volume 29, Number 4, October 2009 , pp. 143-156(14)

Publisher: Blackwell Publishing

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Authors: Paschos, Konstantinos A.; Veletza, Stavroula; Chatzaki, Ekaterini

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 755-772(18)

Publisher: Adis International

Agomelatine: Innovative Pharmacological Approach in Depression

Author: Popoli, Maurizio

Source: CNS Drugs, Volume 23, Supplement 2, 1 September 2009 , pp. 27-34(8)

Publisher: Adis International

Variation in the CYP2D6 gene is associated with a lower serum sodium concentration in patients on antidepressants

Authors: Kwadijk-de Gijsel, Sonja; Bijl, Monique J.; Visser, Loes E.; van Schaik, Ron H. N.; Hofman, Albert; Vulto, Arnold G.; van Gelder, Teun; Ch. Stricker, Bruno H.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 2, August 2009 , pp. 221-225(5)

Publisher: Blackwell Publishing

Low-dose doxepin for the treatment of insomnia: emerging data

Author: Goforth, Harold W

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 10, July 2009 , pp. 1649-1655(7)

Publisher: Informa Healthcare

Amitriptyline inhibits the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes

Authors: Baik, Hee-Jung; Lee, Soon-Ae; Washington, Jacqueline M.; Zuo, Zhi-yi

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 5, May 2009 , pp. 577-581(5)

Publisher: Pharmaceutical Press

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

Authors: Braida, Daniela; Capurro, Valeria; Zani, Alessia; Rubino, Tiziana; Viganò, Daniela; Parolaro, Daniela; Sala, Mariaelvina

Source: British Journal of Pharmacology, Volume 157, Number 5, July 2009 , pp. 844-853(10)

Publisher: Blackwell Publishing

Antidepressants and Falls in the Elderly

Authors: Darowski, Adam; Chambers, Sally-Ann C.F.; Chambers, David J.

Source: Drugs & Aging, Volume 26, Number 5, May 5 2009 , pp. 381-394(14)

Publisher: Adis International

Current investigational drugs for major depression

Authors: Kulkarni, Shrinivas K; Dhir, Ashish

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 767-788(22)

Publisher: Informa Healthcare

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1559-1562(4)

Publisher: Bentham Science Publishers

Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

Authors: Lopez-Munoz, Francisco; Alamo, Cecilio

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1563-1586(24)

Publisher: Bentham Science Publishers

Opiates as Antidepressants

Authors: Berrocoso, Esther; Sanchez-Blazquez, Pilar; Garzon, Javier; Mico, Juan A.

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1612-1622(11)

Publisher: Bentham Science Publishers

New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways

Authors: Nishida, Akira; Miyaoka, Tsuyoshi; Inagaki, Takuji; Horiguchi, Jun

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1683-1687(5)

Publisher: Bentham Science Publishers

Mirtazapine: A Review of its Use in Major Depression and Other Psychiatric Disorders

Authors: Croom, Katherine F.; Perry, Caroline M.; Plosker, Greg L.

Source: CNS Drugs, Volume 23, Number 5, 19 May 2009 , pp. 427-452(26)

Publisher: Adis International

How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003-6

Authors: Smith, Alesha J.; Tett, Sue E.

Source: Drugs & Aging, Volume 26, Number 2, 2009 , pp. 113-122(10)

Publisher: Adis International

Clinical diagnosis and treatment of suspected neuropathic pain in three dogs

Authors: Cashmore, RG; Harcourt-Brown, TR; Freeman, PM; Jeffery, ND; Granger, N

Source: Australian Veterinary Journal, Volume 87, Numbers 1-2, January/February 2009 , pp. 45-50(6)

Publisher: Blackwell Publishing